ORMP oramed.com: Narxning prognoz qilingan daromadga nisbati
Oramed Pharmaceuticals insulinni inyeksiyasiz yuborish uchun innovatsion kapsulalarni joriy qilmoqda, bu esa barqaror talabni ta'minlaydi. Uning Isroil kelib chiqishi va gumanitar maqomi geosiyosiy tahdidlarni minimallashtiradi. Forward P/S tendentsiyasi bozor kutganlarini vizuallashtiradi, bunda joriy parametr 84.30 ga tengdir. Ignachalardan voz kechib, oral shakllarga o'tish tibbiy chiqindilarni tubdan kamaytiradi va ESG tamoyillarini qo'llab-quvvatlaydi.
ORMP (oramed.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Oramed Pharmaceuticals|ORMP - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Oramed Pharmaceuticals Inc.|ORMP - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati ORMP|ORMP - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Oramed Pharmaceuticals|Tezkor likvidlik koeffitsiyenti oramed.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ORMP - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Oramed Pharmaceuticals|ORMP - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Oramed Pharmaceuticals Inc.|ORMP - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati ORMP|ORMP - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Oramed Pharmaceuticals|ORMP - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi oramed.com|ORMP - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Oramed Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Oramed Pharma (ORMP)
Oramed Pharmaceuticals (ORMP) kompaniyasida oral insulinning ishonchli taqsimoti va ta'minot zanjirining qat'iy nazorati prognoz qilingan savdo o'sishi uchun asos yaratadi. Kelgusi yil uchun kutilayotgan daromadga nisbatan bozor kapitalizatsiyasi ko'rsatkichini aks ettiruvchi forward price-to-sales baholash tendentsiyasi investorlarga kelajakdagi biznes kengayish sur'atlari uchun premiumni baholash va ko'paytiruvchi koeffitsiyentlar qisqarishi risklarini o'z vaqtida aniqlash imkonini beradi.
Muhim raqobatchilar
Narxning prognoz qilingan daromadga nisbati Haleon HLN|Kenvue Inc (KVUE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|VRNA - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx MENS (Jyong Bio)|LGND: Forvard P/S multiplikatori|amneal.com (AMRX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Perrigo|Forvard narx/daromad multiplikatori Alvotech S.A. (ALVO)|Forvard P/S multiplikatori LQDA|GLPG - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals)|MNKD: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira Pharmaceuticals)|ARS Pharma (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati TBPH (Theravance Corp)|AQST (Aquestive Therapeutics) - Forvard P/S multiplikatori|SCPH: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori TECX|Forvard P/S multiplikatori Tonix Pharma (TNXP)|Narxning prognoz qilingan daromadga nisbati China SXT Pharmaceuticals, Inc. SXTC|Sotuvga nisbatan forvard narx EPRX|BHST - Narxning prognoz qilingan daromadga nisbati|invizyne.com (EXOZ) - Forvard narx/daromad multiplikatori|ENTX: Forvard P/S multiplikatori|MindWalk Holdings, Inc. (HYFT) - Forvard P/S multiplikatori|ABVC (ABVC BioPharma Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cumberland Corp (CPIX)|Forvard P/S multiplikatori QNTM|FGEN - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Telomir Pharmaceuticals, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Rani Therapeutics Holdings RANI|SNYR: Forvard narx/daromad multiplikatori|Rallybio Corporation - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|PULM - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|PTHL (Pheton Holdings Limited) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Aptorum (APM)|Forvard P/S multiplikatori LYRA|Forvard P/S multiplikatori Impact BioMedical, Inc. (IBO)|Narxning prognoz qilingan daromadga nisbati TNF Pharmaceuticals, Inc. TNFA|cbdMD Inc. - Narxning prognoz qilingan daromadga nisbati|PRFX - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Altamira Therapeutics CYTO|Lipella (LIPO) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati OptiNose Corp (OPTN)|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard narx/daromad multiplikatori Qilian International Holding Group QLI|Narxning prognoz qilingan daromadga nisbati ACELYRIN, Inc. SLRN|TFFP (TFF Pharmaceuticals, Inc) - Kelajakdagi narxning daromadga nisbati
